AHFS December 2023 Update

This update contains 11 new monographs, 20 revised monographs and 2 new MedWatch alerts.

New monographs: Albuterol Sulfate and Budenoside; Betibeglogene Autotemcel; Brexucabtagene Autoleucel; Cipaglucosidase Alfa-atga; Elivaldogene Autotemcel; Miglustat (Pompe Disease); Niraparib Tosylate and Abinoserone Acetate; Onasemnogene Abeparvovec-xioi; Sipuleucel-t; Voretigene Neparvovec-rzyl; Zuranolone.

Revised monographs: Argatroban; Bupivacaine and Meloxicam; COVID-19 Vaccine, mRNA (Moderna); COVID-19 Vaccine, mRNA (Pfizer-BioNTech); Dulaglutide; Edaravone; Enfuvirtide; Exenatide; Influenza Vaccine Live Intranasal; Influenza Vaccine Recombinant; Liraglutide; Lixisenatide; Maraviroc; Mitapivat sulfate; Propofol; Rilpivirine Hydrochloride; Risankizumab-rzaa; Ruxolitinib Phosphate; Semaglutide; Talimogene Laherparepvec.

New MedWatch alerts on the following monographs: Ketamine Hydrochloride; Mobocertinib Succinate.